论文信息 - Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. - 字舞流文

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.

D. Ettinger | R. Salgia | P. Lorigan | D. Spigel | A. Dudek | L. Garbo | M. Renschler | R. Jotte | C. Alemany | P. Conkling | Vicram Gupta | C. Shah | J. Oliver | R. Mcnally